De novo heterozygous variants in KIF5B cause kyphomelic dysplasia.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
07 2022
Historique:
revised: 23 03 2022
received: 07 02 2022
accepted: 24 03 2022
pubmed: 29 3 2022
medline: 16 6 2022
entrez: 28 3 2022
Statut: ppublish

Résumé

Kyphomelic dysplasia is a heterogeneous group of skeletal dysplasias characterized by severe bowing of the limbs associated with other variable findings, such as narrow thorax and abnormal facies. We searched for the genetic etiology of this disorder. Four individuals diagnosed with kyphomelic dysplasia were enrolled. We performed whole-exome sequencing and evaluated the pathogenicity of the identified variants. All individuals had de novo heterozygous variants in KIF5B encoding kinesin-1 heavy chain: two with c.272A>G:p.(Lys91Arg), one with c.584C>A:p.(Thr195Lys), and the other with c.701G>T:p.(Gly234Val). All variants involved conserved amino acids in or close to the ATPase activity-related motifs in the catalytic motor domain of the KIF5B protein. All individuals had sharp angulation of the femora and humeri, distinctive facial features, and neonatal respiratory distress. Short stature was observed in three individuals. Three developed postnatal osteoporosis with subsequent fractures, two showed brachycephaly, and two were diagnosed with optic atrophy. Our findings suggest that heterozygous KIF5B deleterious variants cause a specific form of kyphomelic dysplasia. Furthermore, alterations in kinesins cause various symptoms known as kinesinopathies, and our findings also extend the phenotypic spectrum of kinesinopathies.

Identifiants

pubmed: 35342932
doi: 10.1111/cge.14133
doi:

Substances chimiques

KIF5B protein, human 0
Kinesins EC 3.6.4.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-11

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Mortier GR, Cohn DH, Cormier-Daire V, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A. 2019;179(12):2393-2419.
Hirokawa N, Noda Y. Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics. Physiol Rev. 2008;88(3):1089-1118.
Kalantari S, Filges I. 'Kinesinopathies': emerging role of the kinesin family member genes in birth defects. J Med Genet. 2020;57(12):797-807.
Novas R, Cardenas-Rodriguez M, Lepanto P, et al. Kinesin 1 regulates cilia length through an interaction with the Bardet-Biedl syndrome related protein CCDC28B. Sci Rep. 2018;8(1):3019.
Seyama R, Tsuchida N, Okada Y, et al. Two families with TET3-related disorder showing neurodevelopmental delay with craniofacial dysmorphisms. J Hum Genet. 2021;67:157-164.
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434-443.
Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812-3814.
Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248-249.
Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575-576.
Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310-315.
Alegria A, Schmitt D, Ramos L, Abreu E, Santos C. Kyphomelic dysplasia, phenotypic variability and presence of a caudal appendage. Pediatr Radiol. 2002;32(12):910-911.
Pryde PG, Zelop C, Pauli RM. Prenatal diagnosis of isolated femoral bent bone skeletal dysplasia: problems in differential diagnosis and genetic counseling. Am J Med Genet A. 2003;117(3):203-206.
Spranger J, Hall BD, Häne B, Srivastava A, Stevenson RE. Spectrum of Schwartz-Jampel syndrome includes micromelic chondrodysplasia, kyphomelic dysplasia, and Burton disease. Am J Med Genet. 2000;94(4):287-295.
Le Merrer M, Cormier Daire V, Maroteaux P. Re-evaluation of kyphomelic dysplasia. Am J Med Genet A. 2003;120(2):289-291.
Corder WT, Hummel M, Miller C, Wilson NW. Association of kyphomelic dysplasia with severe combined immunodeficiency. Am J Med Genet. 1995;57(4):626-629.
Gan H, Xue W, Gao Y, et al. KIF5B modulates central spindle organization in late-stage cytokinesis in chondrocytes. Cell Biosci. 2019;9:85.
Santos-Ledo A, Garcia-Macia M, Campbell PD, Gronska M, Marlow FL. Kinesin-1 promotes chondrocyte maintenance during skeletal morphogenesis. PLoS Genet. 2017;13(7):e1006918.

Auteurs

Toshiyuki Itai (T)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Zheng Wang (Z)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.

Gen Nishimura (G)

Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan.

Hirofumi Ohashi (H)

Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan.

Long Guo (L)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.

Yasuhiro Wakano (Y)

Department of Pediatrics, Toyohashi Municipal Hospital, Toyohashi, Japan.

Takahiro Sugiura (T)

Department of Pediatrics, Toyohashi Municipal Hospital, Toyohashi, Japan.

Hiromi Hayakawa (H)

Department of Obstetrics, Aichi Children's Health and Medical Center, Obu, Japan.

Mayumi Okada (M)

Department of Obstetrics and Gynecology, Genome Medical Center, Toyohashi Municipal Hospital, Toyohashi, Japan.

Takashi Saisu (T)

Department of Pediatric Orthopaedics, Chiba Child & Adult Orthopaedic Clinic, Chiba, Japan.

Ayana Kitta (A)

Department of Orthopedic Surgery, Tokyo Women's Medical University, Yachiyo Medical Center, Chiba, Japan.

Hiroshi Doi (H)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Kenji Kurosawa (K)

Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.

Yoshihiro Hotta (Y)

Department of Ophthalmology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Katsuhiro Hosono (K)

Department of Ophthalmology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Miho Sato (M)

Department of Ophthalmology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Kenji Shimizu (K)

Division of Clinical Genetics and Cytogenetics, Shizuoka Children's Hospital, Shizuoka, Japan.

Kazuharu Takikawa (K)

Department of Pediatric Orthopedics, Shizuoka Children's Hospital, Shizuoka, Japan.

Seiji Watanabe (S)

Department of Pediatrics, Izu Medical and Welfare Center, Izunokuni, Japan.

Naho Ikeda (N)

Department of Neonatology, Juntendo University Shizuoka Hospital, Shizuoka, Japan.

Mitsuyoshi Suzuki (M)

Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.

Atsushi Fujita (A)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Yuri Uchiyama (Y)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan.

Naomi Tsuchida (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan.

Satoko Miyatake (S)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Clinical Genetics Department, Yokohama City University Hospital, Yokohama, Japan.

Noriko Miyake (N)

Departmentof Human Genetics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Shiro Ikegawa (S)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH